Emmagenics SRL
Emmagenics reported total assets of 643,095 € at the end of the 2025 financial year (annual accounts filed with the NBB on 16 Jul 2026).
The score of Emmagenics shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +196 % Total assets +113 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Emmagenics's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 16 Jul 2026
- Year ended 31 Dec 2024filed on 01 Jul 2025
- Year ended 31 Dec 2023filed on 30 Jul 2024
Emmagenics's financial analysis
- Solvency14.6%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Emmagenics
Emmagenics's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0786.877.064
- VAT number
- BE0786877064
- Peppol
- Registered · 0208:0786877064 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 Jun 2022
- Registered office
- 9051 Ghent
- Latest accounts
- 2025 · filed on 16 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Emmagenics (SRL) has been based in Ghent since 2022, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 171,314 € and equity of 93,815 €; its revenue is not published. Its solvency stands at 14.6%, below the median of its sector (46.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Emmagenics
Companies in the same business, of comparable size and area, outside its group.
- Lupumed Wholesale of pharmaceutical and medical goods Ghent · balance sheet €2.08m
- Pharma & More Wholesale of perfume and cosmetics Destelbergen · balance sheet €4.43m
- Fagron Belgium Wholesale of pharmaceutical and medical goods Nazareth-De Pinte · balance sheet €7.86m
- Sanifort Pharma Wholesale of pharmaceutical and medical goods Leuven · balance sheet 408,425 €
- Vesale Pharma Woman Health Wholesale of pharmaceutical and medical goods Éghezée · balance sheet 62,158 €
- Jovilux Wholesale of perfume and cosmetics Oudenaarde · balance sheet 929,444 €
- Amazing SRL Wholesale of perfume and cosmetics Anderlecht · balance sheet 789,655 €
- EZI Biolab Wholesale of perfume and cosmetics Oupeye · balance sheet 599,741 €
Frequently asked questions about Emmagenics
What is the revenue of Emmagenics?
Emmagenics files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Emmagenics?
In Belgium, the VAT number is the company number prefixed with BE: BE0786877064 for Emmagenics, if the company is VAT-registered. Its company number (CBE) is 0786.877.064.
Where is the registered office of Emmagenics?
According to the CBE register, the registered office of Emmagenics is in 9051 Ghent.
What is the equity of Emmagenics?
At the close of the 2025 financial year, the equity of Emmagenics amounts to 93,815 €, a solvency of 14.6% of total assets.
Who manages Emmagenics?
The register lists 2 active mandates at Emmagenics. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Emmagenics
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →